The Structural Formula Of Nepafenac (Nevanac 01)
Nevanac
Product Images NDC 0078-0778
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nevanac (NDC 0078-0778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel Ndc 0078-0778-03 Sterile Nevanac® (nepafenac Ophthalmic Suspension) 0.1% 3 mL Novartis (Nevanac 02)
This is a medication in eye-drop form with active ingredient nepafenac 0%. The other ingredients include a small concentration of benzalkonium chloride as a preservative, carbomer, edetate disodium, purified water, sodium chloride, sodium hydroxide, and boric acid. This medication is typically used for ophthalmic purposes and comes in a 0.1% suspension form. The suggested dosage is one drop in the affected eye(s) three times daily and should be shaken before use. It should be stored at a temperature between 2-25°C. The medication is produced by the company Novartis.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
